It was deemed safe vaccine for coronavirus of Pfizer/ BionTech for children aged 5 to 11 years. According to an announcement by the two companies, the vaccine is safe and produced large numbers of antibodies in children of this age, as large-scale research has shown. The conclusion of the research, according to a Bloomberg article, could pave the way for the vaccination of primary school children in a few months.
Pressure to vaccinate children has risen in the US, where the new school year has begun, as Delta mutation has caused an increase in cases.
The study involved 2,268 people who received two doses of 10 micrograms – 1/3 of the dose given to adults – and produced antibody levels similar to those in studies aged 16-25 that received the dose for adults with the same side effects.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
